|Bid||39.00 x 1800|
|Ask||39.01 x 1200|
|Day's Range||38.71 - 39.03|
|52 Week Range||33.26 - 42.68|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||16.38|
|Forward Dividend & Yield||2.20 (5.63%)|
|Ex-Dividend Date||Aug 19, 2021|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for GSKLearn more
GSK Consumer Healthcare (LSE/NYSE: GSK) is raising a cup – or two – of coffee to celebrate enjoying life's simple pleasures without the interruption of tooth sensitivity. Joy – something we haven't had much of throughout the pandemic – is all about feeling good in small and seemingly simple moments, but for those who suffer from sensitive teeth, something as little as enjoying a cup of coffee might not be so joyful.
LONDON, September 28, 2021--FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV
LONDON, July 29, 2021--GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps.